| Schedule of earnings (loss) per share | |
| | | |
| | | |
| | | |
| | |
| | |
|
Three months ended May 31, | | |
|
Nine months ended May 31, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Net loss attributable to shareholders | |
$ | (218 | ) | |
$ | (2,639 | ) | |
$ | (1,758 | ) | |
$ | (2,525 | ) |
| Weighted average number of common shares for basic EPS(1) | |
| 293,920,641 | | |
| 290,792,725 | | |
| 293,040,937 | | |
| 289,148,445 | |
| Effect of dilutive stock options, warrants, restricted share units (“RSU”) and share awards | |
| — | | |
| — | | |
| — | | |
| — | |
| Weighted average number of common shares for diluted EPS(1) | |
| 293,920,641 | | |
| 290,792,725 | | |
| 293,040,937 | | |
| 289,148,445 | |
(1)
The weighted average number of common shares for basic and diluted EPS include 10.3 million of vested,
but unissued, gross common shares relating to share-based compensation.
|